Otifix
DÁVI Produto Otifix
New

Composition

Dexamethasone 1 mg/ml + Ciprofloxacin 3 mg/ml

Ear drops, suspension

Description

Otifix is a suspension for auricular use (in the ear).

Otifix is indicated for the treatment of the following infections in adults, adolescents and children:

  • Acute otitis media in patients with tympanostomy tubes (AOMT), from 6 months of age
  • Acute otitis externa (AOE), from 1 year of age

Prescription-only medicine

Morada da Sede
Rua Alto do Montijo
13 ED Monsanto
2790-012 Carnaxide, Portugal
Telefone
+351 21 434 00 00
(Chamada para rede fixa nacional)
Email e candidaturas
geral@davi.pt
DAVI II – FARMACÊUTICA, S.A.
Estrada Consiglieri Pedroso, 69 B – Queluz de Baixo – 2730-055 Barcarena,
Sociedade Anónima – Matriculada na Conservatória do Registo Comercial de Cascais, sob o nº 508 309 450 Capital Social 217.203,00€
Nº de contribuinte 508 309 450
DÁVI II - FARMACÊUTICA, S.A. – All rights reserved – Privacy Policy – by